Genpax | bacteria
top of page
IET Badge 2023 - Excellence and innovation Awards Winner_RGB (002).jpg

Winners of the 2023 IET Health Technology award

Connecting Pathogen Genomics 

Genpax is revolutionizing the way bacteria and their antimicrobial resistances are tracked across the world 

An estimated 7.7 million deaths are associated with bacterial infections annually at a significant cost to the global economy.

The steady rise of antimicrobial resistance indicates a regression to pre-antibiotic times, forecasting 10 million annual deaths by 2050.

Original on Transparent.png

Genpax's analysis platform, IDEM, is the highest-resolution, globally connectable, whole genome sequencing surveillance tool for infectious diseases

IDEM analyses and interrogates whole genome sequencing data to inform and connect healthcare and public health to contain and curtail outbreaks

Our mission is to provide the highest quality analysis and deliver a global solution in the fight against bacteria

Benefits

Identify outbreaks within and across sites to improve patient and public health

Reduce healthcare associated infections and preventable deaths

Increase hospital capacity and reduce healthcare costs

Improve food and environmental safety

Democratize access to whole genome sequencing

healthcare sureillance of pathogens

Healthcare

Revolutionize infection prevention and control 

Public Health pathogen surveillance with Genpax

Public Health

Reform public health surveillance across any number of laboratories

Food safety wgs with Genpax

Food and Animal Safety

Track and trace pathogens throughout the food chain

Latest News

Pharmaceuticals wgs pathogens Genpax

Life Sciences

Advanced pathogen analysis for a range of functions

bottom of page